Gene Symbol | Gene ID | Gene Info |
---|---|---|
Aire
|
ENSMUSG00000000731.9 | autoimmune regulator (autoimmune polyendocrinopathy candidiasis ectodermal dystrophy) |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr10_78028225_78028390 | Aire | 9951 | 0.107598 | -0.46 | 3.8e-04 | Click! |
chr10_78043681_78043832 | Aire | 146 | 0.910864 | -0.39 | 3.0e-03 | Click! |
chr10_78043436_78043658 | Aire | 25 | 0.947292 | -0.39 | 3.4e-03 | Click! |
chr10_78032076_78032227 | Aire | 6107 | 0.117505 | 0.23 | 8.6e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr10_25299127_25299474 | 7.57 |
Akap7 |
A kinase (PRKA) anchor protein 7 |
136 |
0.89 |
chr3_125270894_125271310 | 7.17 |
Gm42826 |
predicted gene 42826 |
51549 |
0.18 |
chr3_153852117_153852268 | 6.94 |
Asb17os |
ankyrin repeat and SOCS box-containing 17, opposite strand |
209 |
0.88 |
chr17_56826728_56827077 | 6.49 |
Rfx2 |
regulatory factor X, 2 (influences HLA class II expression) |
4037 |
0.15 |
chr6_67161663_67162061 | 6.35 |
A430010J10Rik |
RIKEN cDNA A430010J10 gene |
3062 |
0.22 |
chr4_41129904_41130072 | 6.30 |
Gm12402 |
predicted gene 12402 |
2856 |
0.14 |
chr14_40962341_40962654 | 6.26 |
Tspan14 |
tetraspanin 14 |
4310 |
0.22 |
chr16_35807427_35807592 | 6.20 |
Gm26838 |
predicted gene, 26838 |
1437 |
0.31 |
chr18_56870974_56871252 | 6.15 |
Gm18087 |
predicted gene, 18087 |
44975 |
0.14 |
chr9_112996021_112996172 | 6.13 |
Gm36251 |
predicted gene, 36251 |
126933 |
0.06 |
chr1_134460444_134460597 | 6.00 |
Klhl12 |
kelch-like 12 |
4965 |
0.12 |
chr4_115094117_115094298 | 5.92 |
Pdzk1ip1 |
PDZK1 interacting protein 1 |
3275 |
0.19 |
chr12_24715303_24715820 | 5.90 |
Rrm2 |
ribonucleotide reductase M2 |
6532 |
0.14 |
chr5_50126295_50126569 | 5.86 |
4930448I18Rik |
RIKEN cDNA 4930448I18 gene |
24901 |
0.19 |
chr9_44580129_44580422 | 5.85 |
Gm47230 |
predicted gene, 47230 |
648 |
0.47 |
chr5_90476762_90477403 | 5.53 |
Afp |
alpha fetoprotein |
13655 |
0.14 |
chr3_121264351_121264701 | 5.32 |
Tlcd4 |
TLC domain containing 4 |
1186 |
0.4 |
chr6_41684579_41684848 | 5.29 |
Llcfc1 |
LLLL and CFNLAS motif containing 1 |
282 |
0.84 |
chr2_61970046_61970617 | 5.28 |
Gm13555 |
predicted gene 13555 |
341 |
0.92 |
chr1_80030774_80030937 | 5.21 |
Gm28058 |
predicted gene 28058 |
67767 |
0.09 |
chr16_23057712_23057945 | 5.21 |
Kng1 |
kininogen 1 |
37 |
0.94 |
chr9_106398771_106398931 | 5.15 |
Dusp7 |
dual specificity phosphatase 7 |
24232 |
0.09 |
chr9_32101597_32101753 | 5.15 |
Arhgap32 |
Rho GTPase activating protein 32 |
14461 |
0.15 |
chr1_134072956_134073473 | 5.10 |
Btg2 |
BTG anti-proliferation factor 2 |
5906 |
0.14 |
chr3_84036959_84037218 | 5.02 |
Tmem131l |
transmembrane 131 like |
3040 |
0.3 |
chr4_93481257_93481600 | 4.98 |
Gm23443 |
predicted gene, 23443 |
63849 |
0.13 |
chr6_38834841_38835083 | 4.90 |
Hipk2 |
homeodomain interacting protein kinase 2 |
2262 |
0.35 |
chr18_78123265_78123438 | 4.88 |
Slc14a1 |
solute carrier family 14 (urea transporter), member 1 |
20 |
0.98 |
chr4_38461912_38462063 | 4.84 |
Gm12380 |
predicted gene 12380 |
198069 |
0.03 |
chr1_184656869_184657047 | 4.80 |
Gm37800 |
predicted gene, 37800 |
27485 |
0.12 |
chr11_15838946_15839119 | 4.73 |
Gm37319 |
predicted gene, 37319 |
198761 |
0.03 |
chr18_54436351_54436509 | 4.64 |
Redrum |
Redrum, erythroid developmental long intergenic non-protein coding transcript |
14135 |
0.23 |
chr11_78074361_78074827 | 4.63 |
Mir451b |
microRNA 451b |
1353 |
0.16 |
chr17_12385565_12385750 | 4.61 |
Plg |
plasminogen |
6998 |
0.17 |
chr6_23131016_23131314 | 4.59 |
Aass |
aminoadipate-semialdehyde synthase |
1751 |
0.3 |
chr13_83345046_83345211 | 4.56 |
Gm48156 |
predicted gene, 48156 |
155419 |
0.04 |
chr8_84729971_84731532 | 4.49 |
G430095P16Rik |
RIKEN cDNA G430095P16 gene |
7744 |
0.11 |
chr15_82794220_82794587 | 4.46 |
Cyp2d26 |
cytochrome P450, family 2, subfamily d, polypeptide 26 |
109 |
0.93 |
chr8_111312693_111312982 | 4.45 |
Mlkl |
mixed lineage kinase domain-like |
3282 |
0.18 |
chr1_73072233_73072629 | 4.45 |
1700027A15Rik |
RIKEN cDNA 1700027A15 gene |
47862 |
0.15 |
chr9_123589320_123589495 | 4.42 |
Sacm1l |
SAC1 suppressor of actin mutations 1-like (yeast) |
2919 |
0.2 |
chr17_24848583_24848853 | 4.42 |
Fahd1 |
fumarylacetoacetate hydrolase domain containing 1 |
1646 |
0.17 |
chr15_77974560_77974737 | 4.36 |
Eif3d |
eukaryotic translation initiation factor 3, subunit D |
3835 |
0.18 |
chr8_37422796_37422972 | 4.35 |
Gm45654 |
predicted gene 45654 |
21864 |
0.2 |
chr6_114659890_114660158 | 4.32 |
Atg7 |
autophagy related 7 |
1960 |
0.4 |
chr14_75138884_75139052 | 4.28 |
Gm15628 |
predicted gene 15628 |
2056 |
0.24 |
chr12_40891248_40891399 | 4.26 |
Gm19220 |
predicted gene, 19220 |
2162 |
0.26 |
chr16_38371774_38372058 | 4.15 |
Popdc2 |
popeye domain containing 2 |
82 |
0.95 |
chr2_119605771_119605947 | 4.13 |
Oip5os1 |
Opa interacting protein 5, opposite strand 1 |
11556 |
0.1 |
chr13_112833681_112833853 | 4.12 |
Plpp1 |
phospholipid phosphatase 1 |
32904 |
0.12 |
chr16_90044472_90044663 | 4.12 |
Gm2805 |
predicted gene 2805 |
45416 |
0.15 |
chr14_34240754_34241041 | 4.12 |
Gm49201 |
predicted gene, 49201 |
9169 |
0.09 |
chr2_79762768_79763048 | 4.08 |
Ppp1r1c |
protein phosphatase 1, regulatory inhibitor subunit 1C |
23683 |
0.25 |
chr7_123353967_123354476 | 4.07 |
Lcmt1 |
leucine carboxyl methyltransferase 1 |
15563 |
0.17 |
chr2_15164151_15164466 | 4.07 |
Gm13313 |
predicted gene 13313 |
36708 |
0.16 |
chr7_90059784_90060230 | 4.04 |
Gm44861 |
predicted gene 44861 |
17310 |
0.12 |
chr4_144960520_144960811 | 4.04 |
Gm38074 |
predicted gene, 38074 |
1817 |
0.36 |
chr6_125095392_125097556 | 3.99 |
Chd4 |
chromodomain helicase DNA binding protein 4 |
95 |
0.84 |
chr15_80097599_80097884 | 3.99 |
Syngr1 |
synaptogyrin 1 |
129 |
0.92 |
chr11_57960034_57960300 | 3.99 |
Gm12245 |
predicted gene 12245 |
11082 |
0.15 |
chr7_49320016_49320317 | 3.99 |
Nav2 |
neuron navigator 2 |
15912 |
0.21 |
chr15_78412849_78413028 | 3.98 |
Mpst |
mercaptopyruvate sulfurtransferase |
2956 |
0.13 |
chr3_146393120_146393289 | 3.95 |
Gm22078 |
predicted gene, 22078 |
5360 |
0.14 |
chr2_79259353_79259890 | 3.95 |
Itga4 |
integrin alpha 4 |
3674 |
0.29 |
chr3_83026013_83026219 | 3.93 |
Fga |
fibrinogen alpha chain |
40 |
0.97 |
chr3_104672144_104672299 | 3.93 |
Gm29560 |
predicted gene 29560 |
2211 |
0.16 |
chr2_130470081_130470359 | 3.91 |
Ptpra |
protein tyrosine phosphatase, receptor type, A |
19676 |
0.09 |
chr15_36580548_36581460 | 3.89 |
Gm44310 |
predicted gene, 44310 |
2540 |
0.2 |
chr1_179961389_179961657 | 3.89 |
Cdc42bpa |
CDC42 binding protein kinase alpha |
413 |
0.86 |
chr13_11836412_11836699 | 3.87 |
Ryr2 |
ryanodine receptor 2, cardiac |
6901 |
0.24 |
chr7_135818402_135818575 | 3.86 |
6330420H09Rik |
RIKEN cDNA 6330420H09 gene |
35194 |
0.13 |
chr8_122538525_122538990 | 3.83 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
12572 |
0.09 |
chr8_105833879_105834083 | 3.83 |
Tsnaxip1 |
translin-associated factor X (Tsnax) interacting protein 1 |
6229 |
0.09 |
chr7_90065319_90065589 | 3.82 |
Gm44861 |
predicted gene 44861 |
22757 |
0.11 |
chr8_80494188_80494361 | 3.81 |
Gypa |
glycophorin A |
493 |
0.84 |
chr1_156978782_156978959 | 3.81 |
4930439D14Rik |
RIKEN cDNA 4930439D14 gene |
39032 |
0.12 |
chr19_32569381_32569548 | 3.79 |
Gm36419 |
predicted gene, 36419 |
26116 |
0.16 |
chr1_86245788_86245949 | 3.78 |
Armc9 |
armadillo repeat containing 9 |
1302 |
0.35 |
chr17_50020254_50020555 | 3.78 |
AC133946.1 |
oxidoreductase NAD-binding domain containing 1 (OXNAD1) pseudogene |
47577 |
0.13 |
chrX_150564268_150564425 | 3.75 |
Alas2 |
aminolevulinic acid synthase 2, erythroid |
2044 |
0.25 |
chr4_118079198_118079529 | 3.71 |
St3gal3 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 3 |
47481 |
0.11 |
chr16_23029027_23029577 | 3.67 |
Kng2 |
kininogen 2 |
90 |
0.93 |
chr6_33055731_33056078 | 3.63 |
Chchd3 |
coiled-coil-helix-coiled-coil-helix domain containing 3 |
4313 |
0.2 |
chr8_71383540_71383882 | 3.63 |
Nr2f6 |
nuclear receptor subfamily 2, group F, member 6 |
1751 |
0.19 |
chr15_76254074_76254241 | 3.61 |
Mir6953 |
microRNA 6953 |
5966 |
0.07 |
chr7_120861312_120861627 | 3.59 |
Eef2k |
eukaryotic elongation factor-2 kinase |
10280 |
0.13 |
chr2_6331309_6331868 | 3.58 |
AL845275.1 |
novel protein |
8508 |
0.19 |
chr6_31586330_31586508 | 3.57 |
Gm6117 |
predicted gene 6117 |
11452 |
0.17 |
chr17_50904604_50904755 | 3.56 |
Gm25177 |
predicted gene, 25177 |
12362 |
0.28 |
chr15_44738939_44739223 | 3.54 |
Sybu |
syntabulin (syntaxin-interacting) |
8707 |
0.22 |
chr8_13057142_13057324 | 3.53 |
Proz |
protein Z, vitamin K-dependent plasma glycoprotein |
3681 |
0.12 |
chr13_23697544_23698095 | 3.45 |
H4c3 |
H4 clustered histone 3 |
635 |
0.35 |
chr13_45512013_45512170 | 3.45 |
Gmpr |
guanosine monophosphate reductase |
1749 |
0.41 |
chr12_76376769_76376936 | 3.43 |
Zbtb1 |
zinc finger and BTB domain containing 1 |
6586 |
0.1 |
chr15_96343044_96343245 | 3.43 |
Arid2 |
AT rich interactive domain 2 (ARID, RFX-like) |
13696 |
0.2 |
chrX_104545366_104545677 | 3.43 |
Uprt |
uracil phosphoribosyltransferase |
62703 |
0.11 |
chr1_172697541_172697722 | 3.42 |
Crp |
C-reactive protein, pentraxin-related |
424 |
0.82 |
chr18_78335711_78335874 | 3.40 |
Gm6133 |
predicted gene 6133 |
13962 |
0.27 |
chr1_151596031_151596188 | 3.40 |
Fam129a |
family with sequence similarity 129, member A |
24613 |
0.15 |
chr7_99592798_99592978 | 3.38 |
Arrb1 |
arrestin, beta 1 |
1705 |
0.24 |
chr13_107063669_107063832 | 3.38 |
Gm31452 |
predicted gene, 31452 |
55 |
0.97 |
chr8_40869481_40869728 | 3.38 |
Slc7a2 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 |
5344 |
0.17 |
chr14_30242919_30243078 | 3.37 |
Gm47570 |
predicted gene, 47570 |
35260 |
0.16 |
chr2_132695735_132696027 | 3.36 |
Shld1 |
shieldin complex subunit 1 |
2238 |
0.17 |
chr2_27983213_27983394 | 3.36 |
Col5a1 |
collagen, type V, alpha 1 |
34138 |
0.16 |
chr15_80761509_80761660 | 3.34 |
Tnrc6b |
trinucleotide repeat containing 6b |
37058 |
0.13 |
chr13_59738884_59739054 | 3.34 |
1700014D04Rik |
RIKEN cDNA 1700014D04 gene |
3781 |
0.09 |
chr7_14438643_14438820 | 3.32 |
Sult2a8 |
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 8 |
170 |
0.94 |
chr19_55283777_55283993 | 3.32 |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
449 |
0.81 |
chr11_90727827_90728134 | 3.31 |
Tom1l1 |
target of myb1-like 1 (chicken) |
39614 |
0.15 |
chr8_123990766_123991076 | 3.31 |
Abcb10 |
ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
7799 |
0.1 |
chr9_123846579_123846755 | 3.31 |
Fyco1 |
FYVE and coiled-coil domain containing 1 |
2061 |
0.23 |
chr3_14901908_14902059 | 3.30 |
Car2 |
carbonic anhydrase 2 |
15344 |
0.18 |
chr18_82615474_82615645 | 3.30 |
Zfp236 |
zinc finger protein 236 |
2191 |
0.25 |
chr1_156222336_156222944 | 3.30 |
Gm38113 |
predicted gene, 38113 |
4653 |
0.18 |
chr15_36975014_36975169 | 3.29 |
Zfp706 |
zinc finger protein 706 |
26944 |
0.13 |
chr12_103737920_103738559 | 3.28 |
Serpina1b |
serine (or cysteine) preptidase inhibitor, clade A, member 1B |
81 |
0.95 |
chr12_78905382_78905543 | 3.28 |
Plek2 |
pleckstrin 2 |
1502 |
0.39 |
chr2_152811035_152811186 | 3.27 |
Bcl2l1 |
BCL2-like 1 |
17425 |
0.11 |
chr11_61957517_61957822 | 3.27 |
Specc1 |
sperm antigen with calponin homology and coiled-coil domains 1 |
854 |
0.5 |
chr6_120588730_120588993 | 3.26 |
Gm44124 |
predicted gene, 44124 |
8685 |
0.14 |
chr6_23147385_23147574 | 3.26 |
Gm8945 |
predicted gene 8945 |
9141 |
0.13 |
chr12_72535708_72536908 | 3.25 |
Pcnx4 |
pecanex homolog 4 |
75 |
0.97 |
chr9_103274953_103275104 | 3.24 |
1300017J02Rik |
RIKEN cDNA 1300017J02 gene |
8803 |
0.17 |
chr4_49486438_49486629 | 3.24 |
Gm26424 |
predicted gene, 26424 |
12226 |
0.12 |
chr18_36773435_36773616 | 3.24 |
Hars |
histidyl-tRNA synthetase |
3298 |
0.1 |
chr9_94377575_94378055 | 3.23 |
Gm5370 |
predicted gene 5370 |
30311 |
0.19 |
chr14_63110426_63110600 | 3.21 |
Gm23629 |
predicted gene, 23629 |
10977 |
0.12 |
chr7_16815354_16816404 | 3.20 |
Strn4 |
striatin, calmodulin binding protein 4 |
10 |
0.69 |
chr5_65761880_65762224 | 3.19 |
N4bp2os |
NEDD4 binding protein 2, opposite strand |
1305 |
0.26 |
chr10_86351683_86351989 | 3.19 |
Timp3 |
tissue inhibitor of metalloproteinase 3 |
48982 |
0.13 |
chr18_68274381_68274601 | 3.18 |
Mir7219 |
microRNA 7219 |
13518 |
0.15 |
chr11_78065634_78065852 | 3.17 |
Mir144 |
microRNA 144 |
7262 |
0.08 |
chr2_18969656_18969809 | 3.17 |
Pip4k2a |
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha |
28394 |
0.18 |
chr10_127508848_127510720 | 3.16 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr7_133702854_133703005 | 3.16 |
Uros |
uroporphyrinogen III synthase |
313 |
0.83 |
chr14_122911074_122911225 | 3.16 |
4930594M22Rik |
RIKEN cDNA 4930594M22 gene |
1881 |
0.26 |
chr5_103760427_103761185 | 3.16 |
Aff1 |
AF4/FMR2 family, member 1 |
6233 |
0.23 |
chr2_130977974_130978379 | 3.15 |
Atrn |
attractin |
4609 |
0.16 |
chr13_32969548_32969700 | 3.13 |
Serpinb6b |
serine (or cysteine) peptidase inhibitor, clade B, member 6b |
1874 |
0.25 |
chr4_111531055_111531207 | 3.13 |
Agbl4 |
ATP/GTP binding protein-like 4 |
35564 |
0.2 |
chr10_94048249_94048471 | 3.13 |
Fgd6 |
FYVE, RhoGEF and PH domain containing 6 |
12359 |
0.12 |
chr3_110579391_110579542 | 3.12 |
Gm26076 |
predicted gene, 26076 |
14925 |
0.21 |
chr19_59330792_59330955 | 3.12 |
Gm50440 |
predicted gene, 50440 |
6703 |
0.15 |
chr10_98905567_98905872 | 3.12 |
Atp2b1 |
ATPase, Ca++ transporting, plasma membrane 1 |
8687 |
0.28 |
chr18_6760506_6760893 | 3.12 |
Gm7466 |
predicted gene 7466 |
260 |
0.91 |
chr17_85928454_85928786 | 3.12 |
Gm30117 |
predicted gene, 30117 |
41 |
0.99 |
chr13_47077483_47077639 | 3.12 |
Kdm1b |
lysine (K)-specific demethylase 1B |
11103 |
0.11 |
chr5_66081410_66081828 | 3.11 |
Rbm47 |
RNA binding motif protein 47 |
371 |
0.79 |
chr4_105261004_105261461 | 3.11 |
Plpp3 |
phospholipid phosphatase 3 |
103885 |
0.07 |
chr16_93196994_93197290 | 3.09 |
Gm28003 |
predicted gene, 28003 |
124387 |
0.05 |
chr12_17505173_17505324 | 3.08 |
Odc1 |
ornithine decarboxylase, structural 1 |
39546 |
0.11 |
chr2_65820510_65820681 | 3.08 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
25172 |
0.18 |
chr11_31860992_31861143 | 3.07 |
Cpeb4 |
cytoplasmic polyadenylation element binding protein 4 |
11144 |
0.19 |
chr13_112046615_112046776 | 3.07 |
Gm15323 |
predicted gene 15323 |
41193 |
0.14 |
chr1_33624962_33625263 | 3.05 |
Prim2 |
DNA primase, p58 subunit |
1788 |
0.28 |
chr2_165884402_165885933 | 3.05 |
Zmynd8 |
zinc finger, MYND-type containing 8 |
293 |
0.86 |
chr16_76323639_76324221 | 3.05 |
Nrip1 |
nuclear receptor interacting protein 1 |
272 |
0.94 |
chr18_64328769_64328920 | 3.04 |
St8sia3os |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3, opposite strand |
4862 |
0.18 |
chr16_41242684_41242835 | 3.03 |
Gm47276 |
predicted gene, 47276 |
24982 |
0.22 |
chr11_69609481_69609762 | 3.03 |
Atp1b2 |
ATPase, Na+/K+ transporting, beta 2 polypeptide |
3679 |
0.07 |
chr2_131189822_131190272 | 3.01 |
Cdc25b |
cell division cycle 25B |
1303 |
0.26 |
chr13_111905843_111905994 | 3.01 |
Gm9025 |
predicted gene 9025 |
21741 |
0.14 |
chr11_11728119_11728509 | 3.00 |
Gm12000 |
predicted gene 12000 |
31875 |
0.14 |
chr3_84649654_84649933 | 2.99 |
Tmem154 |
transmembrane protein 154 |
16399 |
0.2 |
chr9_43102322_43102480 | 2.99 |
Arhgef12 |
Rho guanine nucleotide exchange factor (GEF) 12 |
3085 |
0.24 |
chr12_8882133_8882284 | 2.99 |
9930038B18Rik |
RIKEN cDNA 9930038B18 gene |
4826 |
0.2 |
chr6_31588196_31588373 | 2.99 |
Gm6117 |
predicted gene 6117 |
13317 |
0.17 |
chr11_29815611_29815762 | 2.98 |
Eml6 |
echinoderm microtubule associated protein like 6 |
5976 |
0.17 |
chr14_17785456_17785612 | 2.98 |
Gm48320 |
predicted gene, 48320 |
14412 |
0.28 |
chr8_79048738_79048943 | 2.98 |
Zfp827 |
zinc finger protein 827 |
20253 |
0.19 |
chr8_120504531_120505568 | 2.98 |
Gm26971 |
predicted gene, 26971 |
15566 |
0.12 |
chr4_124606233_124606577 | 2.96 |
4933407E24Rik |
RIKEN cDNA 4933407E24 gene |
37215 |
0.11 |
chr13_19150766_19150917 | 2.95 |
Amph |
amphiphysin |
31052 |
0.16 |
chr17_85037901_85038175 | 2.95 |
Slc3a1 |
solute carrier family 3, member 1 |
9662 |
0.18 |
chr1_180902923_180903097 | 2.94 |
Pycr2 |
pyrroline-5-carboxylate reductase family, member 2 |
1283 |
0.27 |
chr18_64537841_64538055 | 2.94 |
Atp8b1 |
ATPase, class I, type 8B, member 1 |
17252 |
0.15 |
chr11_32265240_32265445 | 2.94 |
Nprl3 |
nitrogen permease regulator-like 3 |
2205 |
0.17 |
chr16_49895961_49896112 | 2.93 |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
29203 |
0.24 |
chr5_124605098_124605317 | 2.92 |
Tctn2 |
tectonic family member 2 |
6410 |
0.12 |
chr5_75377098_75377280 | 2.92 |
Gm22084 |
predicted gene, 22084 |
5044 |
0.21 |
chr2_38094090_38094253 | 2.92 |
Gm44291 |
predicted gene, 44291 |
13125 |
0.21 |
chr13_112073588_112073874 | 2.91 |
Gm31104 |
predicted gene, 31104 |
64385 |
0.09 |
chr13_109652180_109652468 | 2.90 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
19544 |
0.3 |
chr17_83562566_83562723 | 2.89 |
Cox7a2l |
cytochrome c oxidase subunit 7A2 like |
45314 |
0.16 |
chr8_123819713_123820119 | 2.89 |
Rab4a |
RAB4A, member RAS oncogene family |
7413 |
0.1 |
chr9_116866223_116866394 | 2.88 |
Rbms3 |
RNA binding motif, single stranded interacting protein |
43489 |
0.21 |
chr10_80818698_80818861 | 2.88 |
Jsrp1 |
junctional sarcoplasmic reticulum protein 1 |
5281 |
0.08 |
chr12_3288227_3288378 | 2.88 |
Rab10 |
RAB10, member RAS oncogene family |
21667 |
0.14 |
chr9_63201505_63201702 | 2.88 |
Skor1 |
SKI family transcriptional corepressor 1 |
52642 |
0.12 |
chr2_104663493_104663675 | 2.87 |
Cstf3 |
cleavage stimulation factor, 3' pre-RNA, subunit 3 |
82 |
0.96 |
chr6_125156824_125157022 | 2.86 |
Iffo1 |
intermediate filament family orphan 1 |
3575 |
0.08 |
chr3_129886522_129886843 | 2.85 |
Pla2g12a |
phospholipase A2, group XIIA |
5498 |
0.16 |
chr3_35923204_35923390 | 2.85 |
Dcun1d1 |
DCN1, defective in cullin neddylation 1, domain containing 1 (S. cerevisiae) |
2109 |
0.21 |
chr4_117831622_117831803 | 2.84 |
Slc6a9 |
solute carrier family 6 (neurotransmitter transporter, glycine), member 9 |
2794 |
0.17 |
chr7_118470297_118470455 | 2.83 |
Gm44652 |
predicted gene 44652 |
10119 |
0.15 |
chr2_34762357_34762541 | 2.83 |
Gapvd1 |
GTPase activating protein and VPS9 domains 1 |
7217 |
0.14 |
chr9_100963446_100963618 | 2.80 |
Stag1 |
stromal antigen 1 |
7763 |
0.19 |
chr9_124138054_124138419 | 2.80 |
Ccr5 |
chemokine (C-C motif) receptor 5 |
9488 |
0.21 |
chr1_170610738_170610986 | 2.80 |
Gm7299 |
predicted gene 7299 |
20059 |
0.16 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 5.9 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.9 | 5.8 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.9 | 5.8 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
1.5 | 7.5 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.5 | 5.9 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.5 | 5.8 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
1.3 | 4.0 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.3 | 4.0 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.2 | 3.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.2 | 4.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.2 | 4.7 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
1.0 | 5.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
1.0 | 2.1 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.0 | 4.1 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
1.0 | 2.9 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
0.9 | 2.8 | GO:0000087 | mitotic M phase(GO:0000087) |
0.9 | 2.7 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.9 | 2.7 | GO:0008050 | female courtship behavior(GO:0008050) |
0.9 | 2.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.9 | 1.8 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.9 | 2.6 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.9 | 2.6 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.9 | 1.7 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.8 | 2.5 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.8 | 3.3 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.8 | 4.0 | GO:0097459 | iron ion import into cell(GO:0097459) |
0.8 | 2.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.7 | 3.0 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.7 | 2.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.7 | 0.7 | GO:0070627 | ferrous iron import(GO:0070627) |
0.7 | 2.2 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.7 | 2.2 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.7 | 2.9 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.7 | 2.2 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.7 | 2.9 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.7 | 2.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.7 | 0.7 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.7 | 2.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.7 | 2.8 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.7 | 2.7 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.7 | 2.6 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.7 | 3.3 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.7 | 3.3 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.7 | 2.6 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.7 | 3.3 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.6 | 2.6 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.6 | 2.6 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.6 | 3.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.6 | 1.9 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.6 | 0.6 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.6 | 1.2 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.6 | 3.7 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.6 | 3.0 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.6 | 1.8 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.6 | 11.8 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.6 | 1.8 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.6 | 1.8 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.6 | 2.3 | GO:0009414 | response to water deprivation(GO:0009414) |
0.6 | 2.3 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.6 | 1.7 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.6 | 1.7 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.6 | 0.6 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.6 | 0.6 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.6 | 2.2 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.6 | 1.7 | GO:0046618 | drug export(GO:0046618) |
0.6 | 0.6 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.6 | 6.1 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.6 | 1.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.5 | 1.1 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.5 | 2.7 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.5 | 0.5 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.5 | 2.1 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.5 | 0.5 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.5 | 2.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.5 | 2.1 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.5 | 2.0 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.5 | 3.1 | GO:0006559 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.5 | 1.0 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.5 | 1.0 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.5 | 1.5 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.5 | 1.0 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.5 | 1.5 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.5 | 1.5 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.5 | 1.5 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.5 | 1.9 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.5 | 4.3 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.5 | 1.4 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.5 | 0.9 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
0.5 | 4.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.5 | 1.4 | GO:0016237 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.5 | 0.5 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.5 | 1.4 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.5 | 0.9 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.5 | 1.9 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.5 | 1.4 | GO:0018343 | protein farnesylation(GO:0018343) |
0.5 | 1.4 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.5 | 1.4 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.5 | 1.4 | GO:0097286 | iron ion import(GO:0097286) |
0.4 | 0.4 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.4 | 1.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.4 | 2.2 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.4 | 0.9 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.4 | 0.9 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.4 | 1.8 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.4 | 0.9 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.4 | 0.4 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.4 | 2.2 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.4 | 1.3 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.4 | 2.1 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.4 | 1.7 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.4 | 4.3 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.4 | 2.6 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.4 | 1.7 | GO:0001805 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.4 | 1.3 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
0.4 | 1.7 | GO:0006848 | pyruvate transport(GO:0006848) |
0.4 | 1.3 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.4 | 3.7 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.4 | 0.8 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.4 | 0.8 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.4 | 1.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.4 | 1.2 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.4 | 0.4 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.4 | 1.6 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.4 | 1.6 | GO:0003383 | apical constriction(GO:0003383) |
0.4 | 2.0 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.4 | 2.8 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.4 | 2.8 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.4 | 1.2 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.4 | 2.4 | GO:0015871 | choline transport(GO:0015871) |
0.4 | 1.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.4 | 1.2 | GO:0006222 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.4 | 1.6 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.4 | 0.4 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.4 | 1.6 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.4 | 1.2 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.4 | 1.2 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.4 | 1.6 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.4 | 1.2 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.4 | 1.2 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.4 | 2.7 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.4 | 1.2 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.4 | 1.2 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.4 | 1.2 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.4 | 1.5 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.4 | 0.8 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.4 | 0.8 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.4 | 0.4 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.4 | 1.1 | GO:0008228 | opsonization(GO:0008228) |
0.4 | 3.0 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.4 | 2.6 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.4 | 1.9 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.4 | 1.1 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.4 | 1.9 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.4 | 0.7 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.4 | 4.1 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.4 | 2.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.4 | 1.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.4 | 1.1 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.4 | 2.6 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.4 | 0.7 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.4 | 1.1 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.4 | 0.7 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.4 | 1.8 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.4 | 4.0 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.4 | 1.4 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.4 | 1.4 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.4 | 1.1 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.4 | 1.1 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.4 | 1.1 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.4 | 1.4 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.4 | 1.1 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.4 | 1.4 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.4 | 1.8 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.3 | 0.3 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.3 | 1.7 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.3 | 1.0 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.3 | 0.3 | GO:0042117 | monocyte activation(GO:0042117) |
0.3 | 1.7 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.3 | 1.4 | GO:0072553 | terminal button organization(GO:0072553) |
0.3 | 0.7 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.3 | 1.0 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.3 | 0.7 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.3 | 0.7 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.3 | 1.7 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.3 | 1.3 | GO:0051031 | tRNA transport(GO:0051031) |
0.3 | 1.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.3 | 1.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.3 | 1.6 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.3 | 1.0 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.3 | 1.3 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.3 | 1.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 1.3 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.3 | 0.3 | GO:0052248 | modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) |
0.3 | 1.3 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.3 | 1.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.3 | 1.3 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.3 | 0.3 | GO:0019627 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
0.3 | 1.9 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.3 | 2.2 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.3 | 6.8 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.3 | 1.2 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.3 | 0.6 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.3 | 0.3 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.3 | 1.5 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.3 | 0.9 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.3 | 0.9 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.3 | 0.9 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.3 | 0.9 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.3 | 2.7 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.3 | 2.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 1.8 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.3 | 0.9 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.3 | 1.5 | GO:0036233 | glycine import(GO:0036233) |
0.3 | 1.2 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.3 | 0.9 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.3 | 1.8 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.3 | 0.3 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.3 | 1.2 | GO:0009078 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
0.3 | 10.3 | GO:0006953 | acute-phase response(GO:0006953) |
0.3 | 1.2 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.3 | 3.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.3 | 3.5 | GO:0071616 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.3 | 3.2 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.3 | 1.2 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.3 | 0.9 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.3 | 1.2 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.3 | 0.6 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.3 | 0.6 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.3 | 1.1 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.3 | 1.1 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.3 | 0.9 | GO:0090383 | phagosome acidification(GO:0090383) |
0.3 | 1.1 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.3 | 0.3 | GO:0061724 | lipophagy(GO:0061724) |
0.3 | 2.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.3 | 3.9 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.3 | 1.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.3 | 0.8 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.3 | 0.6 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.3 | 2.5 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.3 | 1.7 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.3 | 1.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.3 | 0.8 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.3 | 1.1 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.3 | 0.8 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.3 | 0.8 | GO:0072718 | response to cisplatin(GO:0072718) |
0.3 | 1.3 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.3 | 1.1 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.3 | 0.8 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.3 | 0.5 | GO:0060374 | mast cell differentiation(GO:0060374) |
0.3 | 2.4 | GO:0070269 | pyroptosis(GO:0070269) |
0.3 | 0.3 | GO:0015677 | copper ion import(GO:0015677) |
0.3 | 0.5 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.3 | 2.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.3 | 2.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.3 | 1.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.3 | 0.5 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.3 | 1.6 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 1.8 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.3 | 1.6 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.3 | 1.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.3 | 1.8 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.3 | 1.3 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.3 | 0.5 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.3 | 1.0 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.3 | 0.5 | GO:0032782 | bile acid secretion(GO:0032782) |
0.3 | 0.5 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.3 | 0.3 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.3 | 4.9 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.3 | 1.0 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.3 | 0.8 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.3 | 0.3 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.3 | 1.0 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.3 | 0.8 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.3 | 0.3 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.3 | 2.0 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.3 | 1.5 | GO:0051168 | nuclear export(GO:0051168) |
0.3 | 0.3 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.3 | 0.8 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.3 | 2.3 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.3 | 0.8 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.3 | 1.3 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.3 | 1.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 0.2 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.2 | 1.2 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.2 | 0.2 | GO:0071733 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.2 | 0.2 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.2 | 1.0 | GO:1902023 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.2 | 1.0 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.2 | 1.5 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.2 | 0.7 | GO:0034214 | protein hexamerization(GO:0034214) |
0.2 | 0.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.2 | 0.2 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 0.7 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.2 | 1.0 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.2 | 4.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.2 | 0.5 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.2 | 1.2 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.2 | 1.7 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.2 | 1.2 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 2.7 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 1.0 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.2 | 1.2 | GO:0015671 | oxygen transport(GO:0015671) |
0.2 | 1.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.2 | 0.7 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.2 | 0.5 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.2 | 0.7 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.2 | 1.9 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.2 | 0.2 | GO:0035799 | ureter maturation(GO:0035799) |
0.2 | 1.0 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.2 | 0.2 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.2 | 0.9 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 0.2 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.2 | 0.7 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.2 | 3.3 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.2 | 0.2 | GO:0061511 | centriole elongation(GO:0061511) |
0.2 | 0.7 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.2 | 0.2 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.2 | 6.7 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.2 | 0.5 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.2 | 0.9 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.2 | 0.9 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.2 | 0.7 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.2 | 0.7 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.2 | 0.5 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.2 | 0.5 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.2 | 1.1 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.2 | 0.5 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.2 | 0.7 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
0.2 | 1.4 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 1.4 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.2 | 1.1 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 0.5 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
0.2 | 1.8 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.2 | 1.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.2 | 0.7 | GO:1901838 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.2 | 0.2 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.2 | 0.2 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.2 | 1.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.2 | 0.9 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.2 | 0.4 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.2 | 1.3 | GO:1901660 | calcium ion export(GO:1901660) |
0.2 | 6.4 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.2 | 2.0 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 3.0 | GO:0032438 | melanosome organization(GO:0032438) |
0.2 | 0.9 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.2 | 0.4 | GO:0006114 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
0.2 | 3.0 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.2 | 0.6 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.2 | 2.1 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.2 | 0.2 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.2 | 0.6 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.2 | 1.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.2 | 0.6 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 0.2 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.2 | 0.4 | GO:0002432 | granuloma formation(GO:0002432) |
0.2 | 0.4 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.2 | 0.2 | GO:1902339 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.2 | 0.4 | GO:0002278 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.2 | 0.2 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.2 | 1.9 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.2 | 1.5 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.2 | 2.1 | GO:0046697 | decidualization(GO:0046697) |
0.2 | 0.6 | GO:0015817 | histidine transport(GO:0015817) |
0.2 | 0.2 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.2 | 4.5 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.2 | 0.6 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.2 | 1.0 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 0.4 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.2 | 0.4 | GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
0.2 | 1.0 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.2 | 0.6 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.2 | 0.4 | GO:0046112 | nucleobase biosynthetic process(GO:0046112) |
0.2 | 0.2 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
0.2 | 1.2 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.2 | 0.4 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.2 | 0.2 | GO:0010039 | response to iron ion(GO:0010039) |
0.2 | 1.6 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.2 | 0.8 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.2 | 0.8 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.2 | 0.6 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.2 | 1.0 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.2 | 1.2 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.2 | 2.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 1.0 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 0.8 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.2 | 0.8 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.2 | 0.6 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 0.2 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.2 | 0.6 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.2 | 0.6 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.2 | 8.9 | GO:0051225 | spindle assembly(GO:0051225) |
0.2 | 0.6 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 1.0 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.2 | 2.9 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.2 | 3.1 | GO:0006213 | pyrimidine nucleoside metabolic process(GO:0006213) |
0.2 | 0.2 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.2 | 1.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.2 | 4.5 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.2 | 1.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 0.2 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.2 | 2.8 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.6 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.2 | 0.6 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 0.9 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.2 | 0.4 | GO:0046461 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.2 | 3.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 0.9 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.2 | 0.2 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.2 | 1.3 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.2 | 0.2 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.2 | 1.9 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.2 | 0.6 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 0.6 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.2 | 0.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.2 | 1.3 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 0.7 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.2 | 0.4 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.2 | 0.2 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.2 | 0.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.2 | 4.7 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.2 | 0.4 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.2 | 0.2 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.2 | 0.5 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 0.9 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.2 | 0.7 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.2 | 0.7 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 0.2 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.2 | 0.7 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.2 | 0.7 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.2 | 0.4 | GO:0051029 | rRNA transport(GO:0051029) |
0.2 | 0.7 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 0.5 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.2 | 0.2 | GO:0072329 | monocarboxylic acid catabolic process(GO:0072329) |
0.2 | 3.0 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.2 | 0.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.2 | 0.5 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.2 | 0.7 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.2 | 0.2 | GO:1901563 | response to camptothecin(GO:1901563) |
0.2 | 0.3 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.2 | 1.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 1.4 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.2 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 0.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 1.0 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.2 | 1.5 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.2 | 0.5 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.2 | 0.7 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.2 | 1.9 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 0.7 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 0.5 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.2 | 0.2 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.2 | 0.5 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 0.2 | GO:0035973 | aggrephagy(GO:0035973) |
0.2 | 1.0 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.2 | 0.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.2 | 1.0 | GO:1902099 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.2 | 0.2 | GO:0051593 | response to folic acid(GO:0051593) |
0.2 | 0.7 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.2 | 7.2 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.2 | 0.2 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.2 | 1.3 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.2 | 0.3 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.2 | 0.7 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 0.7 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.2 | 0.2 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.2 | 0.2 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
0.2 | 2.0 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 1.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 0.5 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 0.5 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.2 | 1.3 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.2 | 1.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 0.5 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.2 | 0.5 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.2 | 0.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 1.0 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 0.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 0.3 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.2 | 3.4 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.2 | 0.6 | GO:0046909 | intermembrane transport(GO:0046909) |
0.2 | 1.0 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.2 | 0.3 | GO:0046886 | positive regulation of hormone metabolic process(GO:0032352) positive regulation of hormone biosynthetic process(GO:0046886) |
0.2 | 2.8 | GO:0009060 | aerobic respiration(GO:0009060) |
0.2 | 1.0 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.2 | 0.5 | GO:0032202 | telomere assembly(GO:0032202) |
0.2 | 0.2 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.2 | 1.8 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 2.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 0.6 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.2 | 0.6 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 1.1 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.2 | 0.3 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.2 | 1.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 0.6 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.2 | 0.5 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.2 | 3.0 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 0.5 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.2 | 0.8 | GO:0019240 | protein citrullination(GO:0018101) citrulline biosynthetic process(GO:0019240) |
0.2 | 0.5 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.2 | 0.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 4.4 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.2 | 0.3 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.2 | 0.5 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.2 | 1.9 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.2 | 0.6 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.2 | 0.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.2 | 0.2 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.2 | 1.1 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 0.5 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.2 | 1.4 | GO:0051601 | exocyst localization(GO:0051601) |
0.2 | 1.5 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.2 | 0.5 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
0.2 | 0.3 | GO:0033047 | regulation of mitotic sister chromatid segregation(GO:0033047) |
0.2 | 0.9 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 0.5 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.2 | 0.5 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.2 | 1.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 0.9 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 0.2 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.1 | 0.1 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.1 | 0.1 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 0.4 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 1.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.1 | GO:0046666 | cochlear nucleus development(GO:0021747) retinal cell programmed cell death(GO:0046666) |
0.1 | 0.4 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 2.2 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.1 | 0.4 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.1 | 0.4 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 2.5 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.7 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.1 | 1.6 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 1.5 | GO:0050779 | RNA destabilization(GO:0050779) |
0.1 | 1.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.4 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) |
0.1 | 0.4 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.7 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.7 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.6 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.1 | 0.3 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.1 | 0.8 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.1 | 0.8 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.4 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.1 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.1 | 0.3 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 1.5 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.1 | 0.4 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
0.1 | 0.6 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.1 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.1 | 0.4 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 1.1 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.1 | GO:0060066 | oviduct development(GO:0060066) |
0.1 | 0.3 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.1 | 0.7 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.1 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.1 | 0.6 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.3 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.1 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.1 | 1.4 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.1 | 1.0 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.3 | GO:0042148 | strand invasion(GO:0042148) |
0.1 | 0.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 1.0 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 0.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.7 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.1 | 1.8 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 1.0 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 0.8 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 1.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 1.1 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.1 | 0.4 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.1 | 0.4 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.5 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.1 | 0.7 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 6.0 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 1.1 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 1.6 | GO:0072662 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.1 | 0.4 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.4 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 1.3 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.4 | GO:0070197 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.3 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 0.7 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.5 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.9 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.4 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.1 | 0.3 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.1 | 0.1 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 0.3 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 1.0 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.1 | 1.8 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.3 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.1 | 1.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.8 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.6 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 1.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.8 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.1 | 0.3 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.1 | 1.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 1.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.4 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.1 | 0.3 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.1 | 0.8 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.2 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 1.6 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.1 | 0.4 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.9 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 1.9 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.1 | 2.0 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.2 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.1 | 0.2 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.1 | 0.6 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.1 | 1.2 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 3.6 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 0.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 1.1 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 1.2 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 1.5 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.8 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.2 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.1 | 0.1 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.1 | 1.1 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.2 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 0.8 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 1.9 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 0.7 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.1 | 0.2 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 0.4 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.6 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.7 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.1 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.1 | 1.4 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.1 | 0.2 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) glandular epithelial cell maturation(GO:0002071) |
0.1 | 0.4 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.4 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.1 | 0.6 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.5 | GO:0060903 | regulation of meiosis I(GO:0060631) positive regulation of meiosis I(GO:0060903) |
0.1 | 0.3 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.1 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 1.0 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 1.2 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.1 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 0.2 | GO:0032898 | neurotrophin production(GO:0032898) |
0.1 | 0.3 | GO:0002921 | negative regulation of humoral immune response(GO:0002921) |
0.1 | 0.5 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 3.0 | GO:0016575 | histone deacetylation(GO:0016575) |
0.1 | 0.9 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.1 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 0.2 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.1 | 0.2 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.1 | 0.2 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.5 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.6 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.3 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.1 | 0.2 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.1 | 0.8 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 0.2 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 0.3 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 0.2 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.1 | 0.2 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.1 | 0.9 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.2 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.1 | 0.3 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.1 | 0.6 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.7 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 1.1 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.3 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 1.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.8 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.6 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 0.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.9 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.1 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 1.5 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.3 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.1 | 0.2 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 0.5 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.3 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 0.4 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.1 | 0.2 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.1 | 0.8 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 1.6 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 1.1 | GO:0044818 | mitotic G2/M transition checkpoint(GO:0044818) |
0.1 | 0.1 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.1 | 0.1 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.1 | 0.4 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.1 | 0.4 | GO:1904181 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.1 | 0.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 0.5 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.5 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.2 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.1 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.1 | 0.2 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.1 | 2.3 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.6 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.4 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.1 | 1.3 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.4 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.8 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.1 | 0.1 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.1 | 0.9 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.3 | GO:0032905 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
0.1 | 1.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 1.3 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.2 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.1 | 0.3 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.1 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.1 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.4 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.7 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.1 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.1 | 0.1 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.1 | 0.6 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.1 | 0.6 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 1.3 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.2 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.1 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.1 | 0.7 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.1 | 2.1 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 0.2 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 2.3 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.2 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.1 | 0.5 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 0.5 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 0.4 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.1 | 0.6 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.1 | 0.5 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.2 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.2 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.1 | 3.6 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 5.1 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.1 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.1 | 0.3 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.3 | GO:0032206 | positive regulation of telomere maintenance(GO:0032206) |
0.1 | 0.2 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.1 | 2.5 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.1 | 0.8 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.1 | 1.2 | GO:0051180 | vitamin transport(GO:0051180) |
0.1 | 1.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.3 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.5 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.3 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
0.1 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 0.7 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.1 | 0.4 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 0.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 0.5 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.1 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.4 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 13.1 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 0.3 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
0.1 | 0.2 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.1 | 0.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 3.1 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.1 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.1 | 0.1 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.1 | 2.9 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 0.8 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.6 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.1 | 1.5 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.1 | 0.6 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.6 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
0.1 | 0.2 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.1 | 0.3 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 0.2 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 1.9 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 0.5 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.4 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.1 | 1.4 | GO:1904356 | regulation of telomere maintenance via telomere lengthening(GO:1904356) |
0.1 | 1.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.4 | GO:0010954 | positive regulation of protein processing(GO:0010954) positive regulation of protein maturation(GO:1903319) |
0.1 | 1.0 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.1 | 1.1 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 0.3 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.3 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.1 | 0.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.3 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.2 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.1 | 1.1 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.1 | 0.9 | GO:1902686 | positive regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902110) mitochondrial outer membrane permeabilization involved in programmed cell death(GO:1902686) |
0.1 | 0.2 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.1 | 0.6 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 1.5 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 0.3 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 0.3 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.3 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.1 | 0.2 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.3 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.4 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 0.3 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.1 | 0.3 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.1 | 0.6 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 1.1 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.4 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.1 | 0.1 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.1 | 0.8 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.6 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.2 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.1 | 0.2 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.3 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.4 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.7 | GO:0006826 | iron ion transport(GO:0006826) |
0.1 | 0.3 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.1 | 0.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.3 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.2 | GO:0071727 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.1 | 0.2 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.2 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.1 | 0.5 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.6 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.3 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 0.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.2 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.4 | GO:0033750 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.1 | 0.1 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.1 | 1.6 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.1 | 0.2 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.1 | 0.2 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.1 | 0.4 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.1 | 0.6 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.3 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.3 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 0.2 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.8 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.1 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.5 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.2 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
0.1 | 0.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 0.1 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.1 | 0.3 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.1 | 0.4 | GO:0015825 | L-serine transport(GO:0015825) |
0.1 | 0.5 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 0.2 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.4 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 1.1 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 0.4 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.6 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.1 | 0.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 0.1 | GO:2000833 | positive regulation of steroid hormone secretion(GO:2000833) |
0.1 | 3.7 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 0.1 | GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) |
0.1 | 0.1 | GO:0072017 | distal tubule development(GO:0072017) |
0.1 | 0.6 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 0.2 | GO:0021764 | amygdala development(GO:0021764) |
0.1 | 0.1 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.1 | 0.2 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 0.5 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 0.2 | GO:0002724 | regulation of T cell cytokine production(GO:0002724) |
0.1 | 0.1 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.1 | 0.1 | GO:0071285 | response to lithium ion(GO:0010226) cellular response to lithium ion(GO:0071285) |
0.1 | 0.2 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.1 | 0.1 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.1 | 0.4 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.1 | 0.2 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.5 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.1 | 0.7 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.2 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.1 | 0.4 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.1 | 0.2 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
0.1 | 1.3 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.1 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 1.3 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.1 | 0.7 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.1 | 0.3 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.4 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.1 | 0.1 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.1 | 0.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.8 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.9 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 0.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.9 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.1 | 1.0 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.1 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.1 | 0.7 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.1 | 0.3 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.1 | 0.3 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.1 | 0.4 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.1 | 2.2 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.1 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 1.5 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.1 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.1 | 0.4 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.1 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.1 | 0.4 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.9 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.1 | 1.2 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.1 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.3 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.1 | 0.1 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.1 | 0.1 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.1 | 0.3 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.1 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.3 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.1 | 0.2 | GO:0042701 | progesterone secretion(GO:0042701) |
0.1 | 1.5 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 1.0 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 0.1 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.1 | 0.8 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 0.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.4 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.1 | 0.1 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.1 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.1 | 0.9 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.1 | 0.1 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.1 | 0.1 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.1 | 0.2 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.1 | 0.7 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 0.1 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) |
0.1 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.1 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.1 | 0.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.2 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 0.2 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.1 | 0.1 | GO:0051181 | cofactor transport(GO:0051181) |
0.1 | 0.3 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.1 | 0.4 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.1 | 0.4 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.2 | GO:1902093 | regulation of sperm motility(GO:1901317) positive regulation of sperm motility(GO:1902093) |
0.1 | 0.8 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.1 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.1 | 0.1 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.1 | 0.2 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.4 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.4 | GO:0000301 | protein targeting to Golgi(GO:0000042) retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.2 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.1 | 1.8 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.1 | 0.8 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.1 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 0.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.1 | GO:1990182 | exosomal secretion(GO:1990182) |
0.1 | 0.2 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 0.1 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.1 | 0.1 | GO:1901799 | negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.1 | 0.3 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.3 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.1 | 0.2 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.1 | 0.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.1 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 0.4 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.1 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 0.2 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.7 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 0.3 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 3.1 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.1 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.1 | 0.1 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.1 | 0.3 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.1 | 0.1 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.1 | 0.3 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 1.9 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 0.2 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.4 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.2 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.1 | 1.1 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.1 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.1 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.3 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.1 | 0.8 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 0.1 | GO:0060100 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.1 | 0.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.1 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 0.5 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.4 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.4 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.1 | 0.2 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.1 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.4 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.1 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.1 | 0.4 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.1 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.1 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.1 | 0.4 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.2 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.1 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
0.1 | 0.1 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.1 | 0.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.2 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.2 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.0 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.1 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.0 | 0.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.4 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.1 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.1 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 0.6 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
0.0 | 1.2 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.4 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.0 | 0.1 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.0 | 0.1 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.0 | 0.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 0.3 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.1 | GO:0035813 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.0 | 0.0 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.0 | 0.1 | GO:0072603 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.0 | 0.1 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.0 | 0.3 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.0 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.0 | 0.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.0 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.0 | 0.3 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.0 | 0.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.2 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.0 | 0.0 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.0 | 0.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.2 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.0 | 0.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.0 | 0.4 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 0.6 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 1.4 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.0 | 0.2 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.0 | 0.1 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.0 | 0.5 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.0 | 0.0 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.0 | 0.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.1 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.0 | 0.3 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.0 | 0.0 | GO:1990144 | intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.0 | 0.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.2 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 0.0 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.0 | 0.1 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.0 | 2.2 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.1 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.0 | 1.2 | GO:0001889 | liver development(GO:0001889) |
0.0 | 0.0 | GO:2000987 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.0 | 0.0 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.0 | 0.3 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.0 | 0.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.2 | GO:0060179 | male mating behavior(GO:0060179) |
0.0 | 0.1 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.0 | 0.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.0 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.0 | 0.8 | GO:0035966 | response to topologically incorrect protein(GO:0035966) |
0.0 | 0.0 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.0 | 0.2 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.5 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.0 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.0 | 0.1 | GO:0010447 | response to acidic pH(GO:0010447) |
0.0 | 1.0 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.5 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.0 | 0.3 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.0 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.0 | 0.0 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.0 | 0.0 | GO:0036503 | ERAD pathway(GO:0036503) |
0.0 | 0.1 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.1 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.0 | 0.0 | GO:0044062 | regulation of excretion(GO:0044062) |
0.0 | 0.3 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 1.0 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 3.6 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.0 | 0.4 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.0 | 0.1 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.0 | 0.2 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.1 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.1 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.0 | 0.1 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.0 | 0.9 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.0 | 0.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 0.6 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.0 | 0.6 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.3 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.0 | 0.2 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.0 | 0.2 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.0 | 0.3 | GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
0.0 | 0.3 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.0 | 0.2 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 1.0 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.2 | GO:0034331 | cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
0.0 | 0.1 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.0 | 0.1 | GO:0042628 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
0.0 | 0.2 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.0 | 0.1 | GO:1902804 | negative regulation of synaptic vesicle transport(GO:1902804) |
0.0 | 0.0 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.0 | 0.1 | GO:0043084 | penile erection(GO:0043084) |
0.0 | 0.7 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.4 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.0 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.1 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.0 | 0.1 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.0 | 0.0 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.0 | 0.2 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 0.0 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.0 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.0 | 0.2 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.1 | GO:2000515 | negative regulation of CD4-positive, alpha-beta T cell activation(GO:2000515) |
0.0 | 0.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.0 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.0 | 0.0 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.7 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.0 | 0.1 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.0 | 0.4 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.1 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.0 | 0.5 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
0.0 | 0.0 | GO:0043174 | nucleoside salvage(GO:0043174) |
0.0 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.1 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.0 | 0.1 | GO:0007031 | peroxisome organization(GO:0007031) |
0.0 | 0.1 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.0 | 0.0 | GO:0009219 | pyrimidine deoxyribonucleotide metabolic process(GO:0009219) |
0.0 | 0.1 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.0 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.0 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.0 | 0.0 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.0 | 0.1 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.0 | 0.1 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.0 | 0.1 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.1 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.0 | 1.1 | GO:0016579 | protein deubiquitination(GO:0016579) protein modification by small protein removal(GO:0070646) |
0.0 | 0.0 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.0 | 0.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 0.1 | GO:0043482 | cellular pigment accumulation(GO:0043482) |
0.0 | 0.3 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.0 | 0.4 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.0 | 0.1 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.0 | 0.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.0 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.0 | 0.1 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.0 | 0.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.0 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.0 | 0.1 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.0 | 0.1 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.0 | 0.0 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.0 | 0.0 | GO:2000209 | regulation of anoikis(GO:2000209) |
0.0 | 0.1 | GO:1903556 | negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.0 | 0.1 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.1 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.0 | 0.0 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.0 | 0.2 | GO:0061013 | regulation of mRNA catabolic process(GO:0061013) |
0.0 | 0.1 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.0 | 0.2 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.0 | 0.0 | GO:0007004 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.0 | 0.0 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.1 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.0 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.2 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.0 | 0.0 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.3 | GO:0045621 | positive regulation of lymphocyte differentiation(GO:0045621) |
0.0 | 0.0 | GO:0071472 | cellular response to salt stress(GO:0071472) |
0.0 | 0.0 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.0 | 0.0 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.0 | 0.2 | GO:0031570 | DNA integrity checkpoint(GO:0031570) |
0.0 | 0.1 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.0 | 0.0 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.0 | 0.0 | GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.0 | 2.3 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 1.2 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.0 | 0.1 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.0 | 0.1 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.3 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.0 | 0.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.0 | 0.1 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.0 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.0 | 0.1 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.0 | 0.0 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.0 | 0.0 | GO:0021586 | pons maturation(GO:0021586) |
0.0 | 0.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.0 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.0 | 0.0 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.0 | 0.1 | GO:0006623 | protein targeting to vacuole(GO:0006623) |
0.0 | 0.0 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.0 | GO:0097050 | type B pancreatic cell apoptotic process(GO:0097050) |
0.0 | 0.1 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.2 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 0.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 | 0.0 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.0 | 0.0 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.0 | 0.1 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.0 | 0.1 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.0 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.0 | 0.0 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.6 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.0 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.0 | 0.0 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.0 | 0.0 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.0 | 0.1 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.0 | 0.2 | GO:0031124 | mRNA 3'-end processing(GO:0031124) |
0.0 | 0.0 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.0 | 0.2 | GO:0007584 | response to nutrient(GO:0007584) |
0.0 | 0.0 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 0.4 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.1 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.0 | 0.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.0 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.0 | 0.0 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.0 | 0.1 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.0 | 0.3 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.0 | 0.0 | GO:0099558 | motor learning(GO:0061743) maintenance of synapse structure(GO:0099558) |
0.0 | 0.1 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.0 | 0.2 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.1 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.1 | GO:1902622 | regulation of neutrophil migration(GO:1902622) |
0.0 | 0.0 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.0 | 0.0 | GO:0071838 | cell proliferation in bone marrow(GO:0071838) regulation of cell proliferation in bone marrow(GO:0071863) |
0.0 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.0 | GO:0032647 | regulation of interferon-alpha production(GO:0032647) |
0.0 | 0.0 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.0 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.0 | 0.0 | GO:0002254 | kinin cascade(GO:0002254) |
0.0 | 0.0 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.0 | 0.1 | GO:0070193 | synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
0.0 | 0.0 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.0 | 0.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.0 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.0 | 0.0 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 0.9 | GO:0032259 | methylation(GO:0032259) |
0.0 | 0.0 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.0 | 0.2 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.0 | 0.0 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.0 | 0.0 | GO:1990874 | regulation of vascular smooth muscle cell proliferation(GO:1904705) positive regulation of vascular smooth muscle cell proliferation(GO:1904707) vascular smooth muscle cell proliferation(GO:1990874) |
0.0 | 0.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.0 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.0 | 0.1 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.0 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) |
0.0 | 0.0 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 5.7 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.1 | 5.6 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.8 | 5.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.8 | 5.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.7 | 2.9 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.7 | 2.8 | GO:0033269 | internode region of axon(GO:0033269) |
0.6 | 1.9 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.6 | 1.9 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.6 | 1.8 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.6 | 1.8 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.6 | 2.2 | GO:1990130 | Iml1 complex(GO:1990130) |
0.6 | 2.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.5 | 2.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.5 | 1.6 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.5 | 2.1 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.5 | 0.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.5 | 2.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.5 | 1.5 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.5 | 4.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.5 | 0.9 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.5 | 1.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.4 | 1.3 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.4 | 2.7 | GO:0005818 | aster(GO:0005818) |
0.4 | 1.7 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.4 | 2.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.4 | 1.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.4 | 4.5 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.4 | 2.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.4 | 1.2 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.4 | 0.8 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.4 | 0.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.4 | 2.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.4 | 1.5 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.4 | 1.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.4 | 1.8 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.4 | 1.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.3 | 1.0 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.3 | 1.0 | GO:0031523 | Myb complex(GO:0031523) |
0.3 | 1.0 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.3 | 1.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.3 | 1.0 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.3 | 0.6 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 1.9 | GO:0000796 | condensin complex(GO:0000796) |
0.3 | 0.6 | GO:0005579 | membrane attack complex(GO:0005579) |
0.3 | 1.0 | GO:0000811 | GINS complex(GO:0000811) |
0.3 | 0.9 | GO:0030891 | VCB complex(GO:0030891) |
0.3 | 1.6 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.3 | 1.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.3 | 1.5 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.3 | 0.9 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.3 | 2.5 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.3 | 1.5 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.3 | 27.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 2.4 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.3 | 0.3 | GO:0000938 | GARP complex(GO:0000938) |
0.3 | 0.3 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.3 | 1.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.3 | 1.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.3 | 1.4 | GO:0061617 | MICOS complex(GO:0061617) |
0.3 | 0.8 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.3 | 1.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 0.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 0.6 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.3 | 0.6 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.3 | 1.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 1.4 | GO:0034709 | methylosome(GO:0034709) |
0.3 | 0.8 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 1.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.3 | 0.3 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.3 | 2.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.3 | 0.8 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.3 | 4.6 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.3 | 1.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 2.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 0.5 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 9.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 5.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 1.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 1.9 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 3.3 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 0.9 | GO:0035339 | SPOTS complex(GO:0035339) |
0.2 | 2.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.2 | 2.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 3.0 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 2.0 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.2 | 2.5 | GO:0032797 | SMN complex(GO:0032797) |
0.2 | 1.3 | GO:0001739 | sex chromatin(GO:0001739) |
0.2 | 0.4 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 0.7 | GO:0097433 | dense body(GO:0097433) |
0.2 | 0.7 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 1.1 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 3.2 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.2 | 0.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 0.6 | GO:0000805 | X chromosome(GO:0000805) |
0.2 | 0.4 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 2.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 5.0 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 1.8 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.2 | 2.9 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 1.4 | GO:0000800 | lateral element(GO:0000800) |
0.2 | 0.4 | GO:0072686 | mitotic spindle(GO:0072686) |
0.2 | 0.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.2 | 1.9 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 2.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 0.6 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 4.6 | GO:0097228 | sperm principal piece(GO:0097228) |
0.2 | 9.2 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.2 | 4.6 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.2 | 0.6 | GO:0000125 | PCAF complex(GO:0000125) |
0.2 | 0.8 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 0.2 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.2 | 3.0 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.2 | 0.7 | GO:0098536 | deuterosome(GO:0098536) |
0.2 | 0.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.2 | 1.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 2.6 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 2.0 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 0.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.2 | 1.5 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 0.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 9.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 2.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.2 | 0.4 | GO:1990391 | DNA repair complex(GO:1990391) |
0.2 | 0.5 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 0.2 | GO:0030135 | coated vesicle(GO:0030135) |
0.2 | 0.5 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 0.7 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.2 | 0.9 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.2 | 1.9 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 1.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 1.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 0.7 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 0.5 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.2 | 7.8 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.2 | 0.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 1.7 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.2 | 2.2 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.2 | 0.7 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 0.5 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 0.7 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 0.8 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.2 | 0.7 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 0.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 0.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 3.1 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 0.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 0.7 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 0.3 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.2 | 0.6 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.2 | 1.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 0.6 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 0.5 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.2 | 9.0 | GO:0000793 | condensed chromosome(GO:0000793) |
0.2 | 1.0 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 0.6 | GO:0070820 | tertiary granule(GO:0070820) |
0.2 | 2.4 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.2 | 0.5 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.2 | 0.5 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 8.9 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 0.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 6.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 0.5 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 6.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 4.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 0.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 3.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 1.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.9 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.6 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.9 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.9 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.4 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 1.0 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.7 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.3 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.4 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 14.8 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 1.3 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.7 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 45.8 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 2.4 | GO:0090544 | BAF-type complex(GO:0090544) |
0.1 | 0.6 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.1 | 0.3 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 0.7 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 7.2 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 7.2 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 3.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.4 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.1 | 0.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.4 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.1 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.4 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 2.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.9 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 0.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 4.1 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 1.5 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 1.1 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.3 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 1.0 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 0.1 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 1.4 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 1.0 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 1.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.5 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 1.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.8 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 1.9 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 14.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.4 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 1.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 0.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 1.6 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 1.6 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.8 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.6 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 2.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 1.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.5 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.9 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.7 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 1.2 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 1.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.6 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 2.0 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 2.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.6 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.1 | 0.7 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 1.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.6 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.3 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.1 | 0.1 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.1 | 1.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.6 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.4 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 1.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 6.1 | GO:0005814 | centriole(GO:0005814) |
0.1 | 1.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 1.1 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 1.1 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.2 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.1 | 0.1 | GO:0030430 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.1 | 3.5 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.4 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.6 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 1.2 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.1 | 0.1 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 1.6 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.3 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 5.9 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 4.6 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 7.4 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 0.2 | GO:1990462 | omegasome(GO:1990462) |
0.1 | 0.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.7 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 0.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.3 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.7 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.1 | 0.5 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 1.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.2 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 1.6 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 4.6 | GO:0098687 | chromosomal region(GO:0098687) |
0.1 | 1.1 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.9 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 1.5 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.3 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 0.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 2.8 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 2.2 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.2 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.1 | 6.6 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.9 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 0.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 1.7 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.2 | GO:0038201 | TOR complex(GO:0038201) |
0.1 | 0.5 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 1.8 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 4.4 | GO:0012506 | vesicle membrane(GO:0012506) |
0.1 | 0.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.7 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.1 | 0.8 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 1.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 3.4 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 1.2 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.2 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.6 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 2.3 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 1.6 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 0.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 5.9 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 9.8 | GO:0030133 | transport vesicle(GO:0030133) |
0.1 | 0.5 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 0.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.1 | GO:0034708 | methyltransferase complex(GO:0034708) |
0.1 | 2.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.3 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.2 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.1 | 0.7 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 0.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.5 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.6 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 0.3 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 0.3 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 1.3 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.8 | GO:0030496 | midbody(GO:0030496) |
0.1 | 53.1 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.5 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 3.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.4 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.1 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.3 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.7 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 9.4 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 0.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 0.2 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.1 | 0.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.4 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 0.4 | GO:0031430 | M band(GO:0031430) |
0.1 | 0.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.1 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 0.7 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.0 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.0 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 56.4 | GO:0031981 | nuclear lumen(GO:0031981) |
0.0 | 0.5 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 1.2 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.3 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 6.0 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 3.7 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.0 | 0.0 | GO:0042827 | platelet dense granule(GO:0042827) |
0.0 | 0.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.9 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 5.5 | GO:0005874 | microtubule(GO:0005874) |
0.0 | 0.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 22.3 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 1.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 0.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.4 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
0.0 | 20.1 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.1 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 1.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.1 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.0 | 0.0 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.2 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 1.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.8 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 1.7 | GO:1990234 | transferase complex(GO:1990234) |
0.0 | 0.0 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.1 | GO:0043203 | axon hillock(GO:0043203) |
0.0 | 0.2 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 3.5 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.1 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.0 | GO:0005819 | spindle(GO:0005819) |
0.0 | 2.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.2 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 7.0 | GO:0015265 | urea channel activity(GO:0015265) |
1.3 | 3.9 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
1.2 | 3.6 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.1 | 3.3 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
1.0 | 4.0 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
1.0 | 2.9 | GO:0004064 | arylesterase activity(GO:0004064) |
0.9 | 5.4 | GO:0008199 | ferric iron binding(GO:0008199) |
0.8 | 3.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.8 | 3.2 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.8 | 2.4 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.8 | 3.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.8 | 2.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.7 | 3.0 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.7 | 3.6 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.7 | 2.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.7 | 0.7 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.7 | 2.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.7 | 3.4 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.7 | 4.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.7 | 2.0 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.7 | 8.6 | GO:0016208 | AMP binding(GO:0016208) |
0.6 | 5.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.6 | 2.4 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.6 | 2.4 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.6 | 1.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.6 | 1.8 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.6 | 2.3 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.6 | 2.8 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.6 | 2.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.5 | 3.3 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.5 | 1.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.5 | 2.6 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.5 | 1.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.5 | 1.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.5 | 4.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.5 | 1.0 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.5 | 3.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.5 | 2.5 | GO:0046790 | virion binding(GO:0046790) |
0.5 | 6.8 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.5 | 6.2 | GO:0019825 | oxygen binding(GO:0019825) |
0.5 | 1.4 | GO:0019961 | interferon binding(GO:0019961) |
0.5 | 3.8 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.5 | 2.8 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.5 | 1.4 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.5 | 1.4 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.4 | 8.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.4 | 2.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.4 | 1.3 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.4 | 0.4 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.4 | 1.3 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.4 | 1.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.4 | 1.3 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.4 | 0.4 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.4 | 1.3 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.4 | 1.6 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.4 | 1.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.4 | 2.0 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.4 | 0.8 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.4 | 1.6 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.4 | 2.0 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.4 | 1.2 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.4 | 4.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.4 | 7.7 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.4 | 2.3 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.4 | 0.4 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.4 | 1.5 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.4 | 2.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.4 | 1.5 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.4 | 2.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.4 | 0.4 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.4 | 1.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.4 | 1.1 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.4 | 1.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.4 | 5.0 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.4 | 4.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.4 | 1.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.4 | 1.4 | GO:0030984 | kininogen binding(GO:0030984) |
0.4 | 1.4 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.4 | 1.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.4 | 1.8 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.3 | 0.3 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.3 | 1.0 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.3 | 0.3 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.3 | 17.8 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.3 | 1.0 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.3 | 1.3 | GO:0045118 | L-histidine transmembrane transporter activity(GO:0005290) azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.3 | 1.0 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.3 | 1.0 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.3 | 1.3 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.3 | 1.7 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.3 | 2.6 | GO:0034046 | poly(G) binding(GO:0034046) |
0.3 | 2.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.3 | 1.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.3 | 1.0 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.3 | 1.3 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.3 | 3.5 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.3 | 1.6 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.3 | 3.5 | GO:0001848 | complement binding(GO:0001848) |
0.3 | 1.3 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.3 | 1.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.3 | 0.3 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.3 | 0.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.3 | 0.6 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.3 | 2.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 0.6 | GO:0004096 | catalase activity(GO:0004096) |
0.3 | 1.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 2.5 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.3 | 0.9 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.3 | 0.3 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.3 | 3.0 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.3 | 1.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.3 | 2.1 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.3 | 2.6 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.3 | 2.3 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.3 | 3.2 | GO:0043176 | amine binding(GO:0043176) |
0.3 | 0.3 | GO:0051425 | PTB domain binding(GO:0051425) |
0.3 | 2.0 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.3 | 2.0 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.3 | 1.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.3 | 1.4 | GO:0016151 | nickel cation binding(GO:0016151) |
0.3 | 0.9 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.3 | 1.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 0.8 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.3 | 2.5 | GO:0005372 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
0.3 | 0.8 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.3 | 0.8 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.3 | 1.9 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.3 | 1.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.3 | 0.8 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.3 | 0.8 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 1.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.3 | 1.9 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.3 | 1.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.3 | 0.3 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.3 | 2.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.3 | 1.4 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.3 | 0.8 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.3 | 1.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.3 | 0.8 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 0.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.3 | 0.8 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.3 | 1.3 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.3 | 2.6 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.3 | 0.8 | GO:1990188 | euchromatin binding(GO:1990188) |
0.3 | 0.8 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.3 | 2.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.3 | 0.8 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.3 | 0.8 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.3 | 1.5 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.3 | 1.0 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.3 | 0.8 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.3 | 1.8 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.3 | 0.8 | GO:0004359 | glutaminase activity(GO:0004359) |
0.3 | 0.8 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.3 | 1.0 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.3 | 0.3 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.3 | 0.5 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.2 | 1.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 1.0 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.2 | 1.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 0.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.2 | 1.2 | GO:0031491 | nucleosome binding(GO:0031491) |
0.2 | 0.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 0.7 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 0.7 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.2 | 0.7 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.2 | 1.9 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.2 | 3.1 | GO:0032183 | SUMO binding(GO:0032183) |
0.2 | 0.7 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 3.6 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.2 | 0.7 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 0.7 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 20.4 | GO:0002020 | protease binding(GO:0002020) |
0.2 | 3.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 0.9 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.2 | 0.7 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.2 | 0.9 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 2.5 | GO:0019841 | retinol binding(GO:0019841) |
0.2 | 2.0 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 0.2 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.2 | 0.9 | GO:0002054 | nucleobase binding(GO:0002054) |
0.2 | 0.7 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 2.0 | GO:0018448 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.2 | 0.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.2 | 2.0 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 0.6 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 1.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 1.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 1.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.2 | 3.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 0.9 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.2 | 1.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.2 | 1.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 1.7 | GO:0034951 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.2 | 2.8 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.2 | 1.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 3.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 0.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 0.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 1.4 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.2 | 0.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.2 | 0.8 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 2.0 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 1.2 | GO:1990405 | protein antigen binding(GO:1990405) |
0.2 | 1.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.6 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.2 | 0.8 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 1.2 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.2 | 1.4 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.2 | 3.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 1.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 0.8 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.2 | 1.0 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 1.7 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 1.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 0.2 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.2 | 2.5 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.2 | 0.6 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.2 | 0.6 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 0.4 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 0.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 3.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 0.7 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.2 | 0.2 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
0.2 | 0.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 3.1 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.2 | 3.1 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 0.4 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 0.2 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.2 | 2.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 3.1 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.2 | 0.5 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) amidine-lyase activity(GO:0016842) |
0.2 | 0.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 0.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 1.2 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.2 | 1.6 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 0.5 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.2 | 5.5 | GO:0030145 | manganese ion binding(GO:0030145) |
0.2 | 3.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 1.8 | GO:0070990 | snRNP binding(GO:0070990) |
0.2 | 0.5 | GO:0019002 | GMP binding(GO:0019002) |
0.2 | 2.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 1.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.2 | 0.9 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 0.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.2 | 0.9 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.2 | 0.7 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 0.2 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 0.3 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.2 | 1.9 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 0.9 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.2 | 0.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 0.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 7.0 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.2 | 0.5 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 1.0 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 0.7 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.2 | 2.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 0.5 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.2 | 0.7 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.2 | 0.7 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 1.5 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 0.3 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.2 | 0.8 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 0.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.2 | 0.7 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.2 | 0.3 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.2 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 0.3 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 1.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 0.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.2 | 1.3 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.2 | 0.8 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 1.9 | GO:0052890 | acyl-CoA dehydrogenase activity(GO:0003995) oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.2 | 0.6 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 2.9 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 1.4 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 1.6 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 0.8 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 1.1 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 0.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 0.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.2 | 0.3 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.2 | 0.2 | GO:0003896 | DNA primase activity(GO:0003896) |
0.2 | 1.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 6.6 | GO:0019209 | kinase activator activity(GO:0019209) |
0.2 | 0.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.2 | 3.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 1.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.2 | 0.2 | GO:0001032 | RNA polymerase III regulatory region DNA binding(GO:0001016) RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.2 | 1.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 0.8 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.2 | 0.5 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.2 | 6.3 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.1 | 0.3 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 3.0 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 1.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 7.1 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 4.3 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.6 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.6 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.1 | GO:0016876 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 4.1 | GO:0070330 | aromatase activity(GO:0070330) |
0.1 | 0.4 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.1 | 1.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.9 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.1 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.1 | 1.1 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.4 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 1.0 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 1.8 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 0.7 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.7 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 3.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 4.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 3.1 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.1 | 0.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.3 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 1.1 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.8 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 0.4 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 1.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 4.6 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 5.5 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 2.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.9 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.3 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 0.8 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.4 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 2.4 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 0.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.7 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 1.8 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 3.6 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.4 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 1.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.8 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.4 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 1.4 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 3.4 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.1 | 2.8 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.9 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 6.1 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.5 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 1.5 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.6 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 1.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.4 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.7 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 1.9 | GO:0050661 | NADP binding(GO:0050661) |
0.1 | 0.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.5 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.2 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 1.5 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 2.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.6 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 0.7 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.1 | 2.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 1.8 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.4 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 5.2 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 0.5 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.4 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 1.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 1.8 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 1.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 1.0 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 2.9 | GO:0052693 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.1 | 1.5 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.3 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.1 | 0.3 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 2.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.2 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 0.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.7 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.2 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.7 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.8 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 1.0 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 1.2 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.4 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 1.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.8 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 3.4 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.1 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 0.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.2 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 2.9 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 0.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 3.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 0.3 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.1 | 2.1 | GO:0016209 | antioxidant activity(GO:0016209) |
0.1 | 1.8 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 0.1 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 0.5 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.9 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.1 | 0.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 2.4 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 10.4 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
0.1 | 0.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 4.1 | GO:0080131 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.1 | 0.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 1.0 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.6 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 3.5 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 1.1 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 1.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 1.8 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 6.8 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.1 | 0.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.6 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 1.2 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.2 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 0.5 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.1 | 0.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 0.2 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 2.4 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.1 | 0.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.5 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 3.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.9 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.7 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 1.6 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.1 | 0.4 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.6 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 1.2 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 2.1 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.5 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.7 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.1 | 1.2 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 1.0 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 1.9 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 1.2 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 0.9 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.1 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.1 | 4.3 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.2 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 2.8 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.3 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 0.4 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 7.3 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.6 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 2.1 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.8 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.1 | 0.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.3 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.1 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 4.2 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.2 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.2 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.1 | 0.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 1.3 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 0.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.7 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 2.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.2 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.1 | 0.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 1.2 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 2.2 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.7 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 2.7 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 1.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.3 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.4 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.1 | 0.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.2 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.2 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 0.4 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 0.6 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.1 | 0.2 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 3.5 | GO:0043492 | ATPase activity, coupled to movement of substances(GO:0043492) |
0.1 | 0.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.2 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.6 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.1 | 1.4 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 2.8 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 0.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 0.9 | GO:0022841 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.1 | 12.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.1 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.4 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 0.1 | GO:0060229 | lipase activator activity(GO:0060229) |
0.1 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.5 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 6.9 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.1 | 2.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.6 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 1.3 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.3 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.1 | 0.5 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 0.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 0.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.6 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.9 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 0.2 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.1 | 0.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.1 | 0.7 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.4 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.3 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.4 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.1 | 0.1 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.1 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.7 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 0.2 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.1 | 0.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 1.5 | GO:0004519 | endonuclease activity(GO:0004519) |
0.1 | 0.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 0.4 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 0.1 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.1 | 0.1 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 0.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.4 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.2 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.4 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.4 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 1.3 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.1 | 0.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.4 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.3 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.5 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.6 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.5 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 1.4 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.4 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.1 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.2 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
0.0 | 0.0 | GO:0036222 | XTP diphosphatase activity(GO:0036222) |
0.0 | 0.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.2 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.1 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 1.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.1 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 0.0 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.6 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 1.7 | GO:0020037 | heme binding(GO:0020037) |
0.0 | 0.2 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.4 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.1 | GO:0005119 | smoothened binding(GO:0005119) |
0.0 | 0.7 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.7 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 2.0 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.1 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.0 | 0.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.1 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.0 | 0.0 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.0 | 0.0 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.0 | 0.3 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.0 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.0 | 1.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.3 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.0 | 0.3 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.0 | 0.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.9 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.0 | 0.4 | GO:0019842 | vitamin binding(GO:0019842) |
0.0 | 0.1 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.0 | 0.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 4.1 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.0 | 0.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.3 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.8 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.0 | 0.5 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.5 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 2.8 | GO:0003729 | mRNA binding(GO:0003729) |
0.0 | 2.0 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.0 | GO:0097617 | annealing activity(GO:0097617) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.3 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.3 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.2 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 2.3 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.0 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 1.4 | GO:0008186 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.6 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.6 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.7 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.0 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 0.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.6 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.1 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 0.4 | GO:0015149 | hexose transmembrane transporter activity(GO:0015149) |
0.0 | 0.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 1.7 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 3.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.6 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 1.7 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.6 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.0 | 0.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 9.7 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 2.3 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.3 | GO:0035326 | enhancer binding(GO:0035326) |
0.0 | 0.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.3 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.0 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) alpha2-adrenergic receptor activity(GO:0004938) |
0.0 | 0.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.2 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.0 | 0.3 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 3.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.0 | 2.3 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.2 | GO:0018602 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.0 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.0 | 0.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.3 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.0 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 2.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.0 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.6 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.0 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.3 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.0 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.0 | 0.0 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.5 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.0 | GO:0097001 | ceramide binding(GO:0097001) |
0.0 | 0.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.3 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.0 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.0 | 0.0 | GO:0016160 | amylase activity(GO:0016160) |
0.0 | 0.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.0 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.0 | 0.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 0.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.4 | 11.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.4 | 3.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.4 | 7.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.4 | 18.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 7.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 1.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.3 | 3.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.3 | 6.7 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 2.6 | ST STAT3 PATHWAY | STAT3 Pathway |
0.3 | 6.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 4.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 9.1 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 1.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 2.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 2.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 2.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 1.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 2.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 6.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 5.4 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 0.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 4.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 0.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 3.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 3.0 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 2.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 1.8 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 5.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 7.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 0.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 1.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 3.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 4.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 6.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 1.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 4.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 5.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 3.7 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 3.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 2.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 1.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 3.7 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 3.3 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 3.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 1.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 3.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 0.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 1.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 1.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 1.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.2 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 1.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 1.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 5.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 1.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 2.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 2.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 0.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 2.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 1.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.1 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 1.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 1.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 0.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 1.0 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 0.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 2.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 1.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 0.6 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 1.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 0.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 1.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 1.0 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 1.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.1 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 11.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.7 | 5.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.7 | 0.7 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.6 | 8.4 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.6 | 9.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.6 | 7.9 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.5 | 5.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.5 | 0.5 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.4 | 3.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.4 | 2.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.4 | 7.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.4 | 1.9 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.4 | 5.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.4 | 3.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.4 | 0.7 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.4 | 5.7 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.4 | 5.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.4 | 5.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.4 | 4.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.4 | 9.1 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.3 | 5.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 0.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.3 | 3.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.3 | 3.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.3 | 1.6 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.3 | 1.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.3 | 2.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 1.7 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.3 | 0.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 2.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.3 | 4.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.3 | 1.1 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.3 | 3.9 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.3 | 1.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.3 | 2.7 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.3 | 5.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.3 | 4.4 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.3 | 2.6 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.3 | 3.6 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.3 | 2.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.3 | 5.7 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.3 | 4.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 2.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 4.2 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.2 | 0.5 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.2 | 0.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.2 | 2.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 0.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.2 | 9.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 4.5 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 2.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.2 | 0.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.2 | 5.7 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 2.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 5.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 4.2 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.2 | 13.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 2.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 1.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 1.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 4.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 0.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 3.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 2.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 2.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 2.6 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.2 | 1.3 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.2 | 1.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 2.1 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.2 | 5.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.2 | 7.5 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.2 | 0.4 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.2 | 1.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 0.7 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 2.0 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 6.4 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.2 | 5.4 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.2 | 2.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 3.0 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.2 | 3.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 1.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 1.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 4.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 13.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 3.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 1.5 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.2 | 2.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 1.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 1.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 1.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 0.3 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 1.7 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 1.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 3.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 0.3 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.1 | 1.8 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 1.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 2.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 17.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 2.8 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 3.0 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 1.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 0.1 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 1.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 5.0 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 0.5 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 3.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 3.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.7 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 1.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 1.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.9 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 1.3 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 1.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 0.6 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.8 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 0.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 0.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 1.2 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.1 | 0.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 2.4 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 0.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.4 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 0.6 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 0.5 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 1.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 1.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 1.8 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 0.6 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 1.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.4 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 3.8 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 0.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 0.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.3 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 0.3 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.1 | 0.1 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 4.5 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 0.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 2.4 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 0.3 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 0.4 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 3.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.8 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.3 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.1 | 0.3 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 2.4 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 2.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 4.6 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.1 | 1.8 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 4.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.4 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.1 | 1.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.4 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 0.7 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 0.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 1.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.9 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 1.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 0.8 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.1 | 4.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 0.6 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.1 | 0.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.1 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.1 | 0.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.6 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.1 | 1.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 2.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.1 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.1 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.1 | 0.5 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 0.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 5.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.1 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.6 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.4 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.2 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.0 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.0 | 0.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.8 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.1 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.0 | 0.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.3 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 0.4 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.4 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 1.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 1.2 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.0 | 0.8 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.0 | 0.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.1 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.5 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.4 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.0 | 0.7 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.1 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.0 | 0.0 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.0 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.1 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.0 | 0.0 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
0.0 | 0.0 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.2 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.0 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.0 | 0.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.0 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.0 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.1 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.0 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.1 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.0 | 0.0 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.1 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |